ARCH Venture Fund VIII, L.P.

Insider Reports History

Location
Chicago, IL
Signature
ARCH Venture Fund VIII, L.P. By: ARCH Venture Partners VIII, L.P., its General Partner By: ARCH Venture Partners VIII, LLC, its General Partner By: /s/ Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ARCH Venture Fund VIII, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Codiak BioSciences, Inc. 10%+ Owner Common Sotck 8,854,098 13 Sep 2022 Indirect
Codiak BioSciences, Inc. 10%+ Owner Warrant (Right to Buy) 5,000,000 13 Sep 2022 Direct

Insider Reports Filed by ARCH Venture Fund VIII, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000106299322019586-arch-venture-fund-viii-l-p-2022-09-13 Codiak BioSciences, Inc. 13 Sep 2022 2 +$7,500,000 4 10%+ Owner 15 Sep 2022, 18:53